Christopher Haqq, Chief Medical Officer at Atara Biotherapeutics, Inc. (ATRA), sold 14,136 shares at $17.85 ($252K) on 2016-11-21, disclosed to the SEC on 2016-11-22.
Open-market sale of $252k ATRA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.85 | 7,068 | $126K | 50.0% |
| 2 | $17.85 | 7,068 | $126K | 50.0% |
| Total | $17.85 avg | 14,136 | $252K | 100% |
| Filing → |
| ATRA | SELL | 2019-02-08 | $956K | — | Filing → |
| ATRA | SELL | 2018-11-15 | $26K | — | Filing → |
| ATRA | SELL | 2018-09-27 | $582K | — | Filing → |